Literature DB >> 2687529

Glucagon in the metabolic and nutritional management after total pancreatectomy--a case report.

M Hirota1, S Ikei, M Mishima, K Mori, K Sakamoto, T Yamane, K Idegami, S Katafuchi, H Kiyohara, Y Nakashima.   

Abstract

The effects of exogenous glucagon on a totally pancreatectomized patient were evaluated in both the acute postoperative and convalescent periods. In the acute postoperative phase, glucagon stabilized the blood glucose level and allowed the administration of an adequate amount of energy, while during the convalescent period, it proved useful in promoting the metabolism of lipids and amino acids and maintaining liver function. Moreover, we developed a glucagon aerosol which enabled frequent administration without causing major discomfort to the patient and raised the blood glucagon to satisfactory level.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2687529     DOI: 10.1007/bf02471668

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  16 in total

1.  Adrenocortical and medullary effects of glucagon.

Authors:  L F SCIAN; C D WESTERMANN; A S VERDESCA; J G HILTON
Journal:  Am J Physiol       Date:  1960-11

2.  Gluconeogenesis from alanine in normal postabsorptive man. Intrahepatic stimulatory effect of glucagon.

Authors:  J L Chiasson; J E Liljenquist; B C Sinclair-Smith; W W Lacy
Journal:  Diabetes       Date:  1975-06       Impact factor: 9.461

3.  Amino acids and lipoproteins in plasma of duodenopancreatectomized patients: effects of glucagon in physiological amounts.

Authors:  W A Müller; H J Cüppers; H Zimmermann-Telschow; H Micheli; T Wyss; A E Renold; M Berger
Journal:  Eur J Clin Invest       Date:  1983-04       Impact factor: 4.686

4.  Glycaemic control in pancreatectomized dogs with a wearable artificial endocrine pancreas.

Authors:  M Shichiri; R Kawamori; Y Goriya; Y Yamasaki; M Nomura; N Hakui; H Abe
Journal:  Diabetologia       Date:  1983-03       Impact factor: 10.122

5.  Influence of estrogen on fat metabolism in totally depancreatized dogs.

Authors:  T Taniguchi
Journal:  Nihon Geka Hokan       Date:  1966-01-01

6.  Comparison of glucagon and epinephrine effects in the dog.

Authors:  E Z Ezdinli; J E Sokal
Journal:  Endocrinology       Date:  1966-01       Impact factor: 4.736

7.  Effect of glucagon on plasma alanine and glutamine metabolism and hepatic gluconeogenesis in sheep.

Authors:  R P Brockman; E N Bergman
Journal:  Am J Physiol       Date:  1975-06

8.  [A reevaluation of the glucagon provocative test for pheochromocytoma--on the in vitro release of catecholamine from the adrenal medulla or pheochromocytoma tissue, and on the effect of intravenous glucagon on urinary catecholamine excretion and blood pressure (author's transl)].

Authors:  T Nakai; R Yamada; M Baba; E Komiya
Journal:  Nihon Naibunpi Gakkai Zasshi       Date:  1980-06-20

9.  Glucagon immunoreactivities and amino acid profile in plasma of duodenopancreatectomized patients.

Authors:  W A Muller; M Berger; P Suter; H J Cüppers; J Reiter; T Wyss; P Berchtold; F H Schmidt; J P Assal; A E Renold
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

10.  A randomized clinical trial of insulin and glucagon infusion for treatment of alcoholic hepatitis: progress report in 50 patients.

Authors:  A L Baker; J B Jaspan; N W Haines; G E Hatfield; P S Krager; J F Schneider
Journal:  Gastroenterology       Date:  1981-06       Impact factor: 22.682

View more
  1 in total

1.  Inhalable sustained-release formulation of glucagon: in vitro amyloidogenic and inhalation properties, and in vivo absorption and bioactivity.

Authors:  Satomi Onoue; Kazuki Kuriyama; Atsushi Uchida; Takahiro Mizumoto; Shizuo Yamada
Journal:  Pharm Res       Date:  2011-02-02       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.